Tag Archives: U.S.

Los Angeles County resident dies of lung illness, fifth U.S. death possibly tied to vaping

(Reuters) – A Los Angeles County resident has died from a lung illness possibly tied to vaping, bringing the total number of such U.S. deaths to five, health officials said on Friday. Officials are warning against e-cigarette use as the exact cause of any link between vaping and the lung condition remains unknown. The unidentified… Read More »

Mylan’s Lantus copy derailed in U.S. again by manufacturing ills

When Biocon’s insulin operations in Malaysia won EU approval two weeks ago, it sounded like the company had turned a quality corner. But that turn is not near sharp enough for the FDA, which has issued a second complete response letter (CRL) for the Lantus competitor Biocon developed with Mylan.  Biocon announced over the weekend… Read More »

Pfizer’s keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S. It’s taken some serious internal organizing on Pfizer’s part, but so far managing the multiple rollouts has been “done very well,”… Read More »